envirosolutions
1000 Twelve Oaks Center Drive, Suite 101
Minneapolis, MN 55391
Phone: (952) 767-3487
Email: info@envirosolutions.net
  August 10, 2008
Douglas J. Smith
Union Hospital Health Group
Director of Materials Management
(Site of the first OZONATOR NG-1000 installation in the United States)
  January 2, 2007
Bill Patrakis
North Carolina Department of Environment and Natural Resources
Environmental Biologist - Division of Waste Management
  July 24, 2006
Ellen Lorscheider
North Carolina Department of Environment and Natural Resources
  March - 2006
Douglas A. F. Saunders
Saskatchewan Corrections and Public Safety Supervisor
- Office of the Fire Commissioner
  February - 2006
Wayne Clifton
Clifton & Associates
  December - 2005
Stefan Wagener, PhD, CBSP
Scientific Director, Biosafety and Environment
Canadian Science Centre for Human and Animal Health
  August - 2005
BDS Laboratories
  August - 2005
Gary Bosgoed, P.Eng.
BOSGOED PROJECT CONSULTANTS LTD. - COLT ENGINEERING
  May - 2005
The first OZONATOR unit, manufactured by Brandt Industries
  February - 2005
Lois Duthie, Health Canada
- Regulatory and Scientific Section
- Licensing Services Medical Devices Bureau
  August - 2004
Colin D. Rasmussen, Ph.D., LL.B.
FURMAN & KALLIO AND UNIVERSITY OF CALIFORNIA
August - 2004

Colin D. Rasmussen, Ph.D., LL.B.
FURMAN & KALLIO AND UNIVERSITY OF CALIFORNIA


Colin D. Rasmusen has a Ph.D. in Cell Biology from Baylor College of Medicine at the Texas Medical Center in Houston, Texas. From 1991 - 1997, he was an Associate Professor of Cell Biology at the University of Alberta, and for part of that time Director of the NCI Molecular Mechanisms in Growth Control Research Group. From 1997 - 2003, he was an Associate Professor of Anatomy & Cell Biology at the University of Saskatchewan. He also has extensive experience in biochemistry, molecular biology and cellular biology, as well as experience in immunology and microbiology.

Mr. Rasmussen has participated in the OZONATOR project by using his extensive scientific background to review the technology and then through the firm of Furman & Kallio, he facilitated the application for world patents on the technology.

The following is an excerpt from his review of the technology:

“The Ozonator system will provide an automated method of treating and disposing of biomedical waste. As handling is minimized, so is the risk of infection to workers. Ozone is not only effective against prions, but against conventional pathogens like bacteria and viruses as well. The finished treated material will be safer to handle than waste treatment by conventional methods. In addition, as ozone naturally dissipates into the atmosphere where it naturally transforms back to oxygen, the use of ozone does not pose an environmental risk like that created by chemical treatment methods”.
 
 
2010 © Copyright - EnviroSolutions. All Rights Reserved